Julian Merz Selected Research

Julian Merz Research Topics

4	Inflammation (Inflammations) 01/2022 - 06/2017
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 11/2021
2	Atherosclerosis 01/2022 - 06/2017
2	Obesity 03/2020 - 10/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2023
1	Myocardial Infarction 11/2022
1	Infections 03/2020
1	Coronary Disease (Coronary Heart Disease) 03/2020
1	Acute Coronary Syndrome 03/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018
1	Insulin Resistance 10/2018

3	CholesterolIBA 01/2022 - 06/2017
2	InflammasomesIBA 01/2022 - 06/2017
2	LDL Receptors (LDL Receptor)IBA 01/2022 - 06/2017
2	Purinergic P2 Receptors (ADP Receptor)IBA 01/2022 - 10/2018
2	Purinergic Receptors (Receptors, Purine)IBA 01/2022 - 10/2018
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 10/2018
1	Particulate MatterIBA 11/2023
1	P-SelectinIBA 11/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	LigandsIBA 01/2022
1	NucleotidesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	CytokinesIBA 01/2022
1	CC ChemokinesIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 11/2021
1	oxidized low density lipoproteinIBA 03/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2020
1	Lipoprotein(a)IBA 03/2020
1	C-Reactive ProteinIBA 03/2020
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2020
1	C-PeptideIBA 10/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2018
1	Insulin (Novolin)FDA Link 10/2018